United States
Securities and Exchange Commission
Washington, D.C. 20549
FORM 10-Q
| x | Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the Quarterly Period Ended March 31, 2004
| ¨ | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the Period from : to
Commission file number 0-22554
OPINION RESEARCH CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 22-3118960 | |
| (State of incorporation) | (I.R.S. Employer Identification No.) | |
| 600 College Road East, Suite #4100 Princeton, NJ |
08540 | |
| (Address of principal executive offices) | (Zip Code) | |
609-452-5400
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes x No ¨
Indicate by check mark whether the Registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2). Yes ¨ No x
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date.
Common Stock, $0.01 Par Value 6,199,698 shares as of May 3, 2004
Opinion Research Corporation and Subsidiaries
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
OPINION RESEARCH CORPORATION AND SUBSIDIARIES
Consolidated Balance Sheets
(in thousands, except share amounts)
(Unaudited)
| March 31, 2004 |
December 31, 2003 |
|||||||
| Assets | ||||||||
| Current Assets: |
||||||||
| Cash and cash equivalents |
$ | 1,062 | $ | 2,766 | ||||
| Accounts receivable: |
||||||||
| Billed |
25,063 | 24,890 | ||||||
| Unbilled services |
15,329 | 14,140 | ||||||
| 40,392 | 39,030 | |||||||
| Less: allowance for doubtful accounts |
270 | 336 | ||||||
| 40,122 | 38,694 | |||||||
| Prepaid and other current assets |
4,038 | 3,161 | ||||||
| Total current assets |
45,222 | 44,621 | ||||||
| Property and equipment, net |
8,684 | 9,099 | ||||||
| Intangibles, net |
602 | 715 | ||||||
| Goodwill |
32,647 | 32,537 | ||||||
| Deferred income taxes |
4,450 | 4,417 | ||||||
| Other assets |
3,886 | 4,322 | ||||||
| $ | 95,491 | $ | 95,711 | |||||
| Liabilities and Stockholders Equity | ||||||||
| Current Liabilities: |
||||||||
| Accounts payable |
$ | 6,445 | $ | 5,473 | ||||
| Accrued expenses |
12,261 | 13,829 | ||||||
| Deferred revenues |
2,950 | 2,183 | ||||||
| Short-term borrowings |
2,000 | 3,000 | ||||||
| Other current liabilities |
805 | 762 | ||||||
| Total current liabilities |
24,461 | 25,247 | ||||||
| Long-term debt |
41,253 | 41,922 | ||||||
| Other liabilities |
1,408 | 1,543 | ||||||
| Redeemable Equity: |
||||||||
| Preferred stock: |
||||||||
| Series B - 10 shares designated, issued and outstanding, liquidation value of $10 per share |
| | ||||||
| Series C - 588,229 shares designated, none issued or outstanding |
| | ||||||
| Common stock, 1,176,458 shares issued and outstanding |
8,900 | 8,900 | ||||||
| Stockholders Equity: |
||||||||
| Preferred stock, $.01 par value, 1,000,000 shares authorized: Series A - 10,000 shares designated, none issued or outstanding |
| | ||||||
| Common stock, $.01 par value, 20,000,000 shares authorized, 5,037,174 shares issued and 4,988,352 outstanding in 2004, and 4,999,159 shares issued and 4,950,337 outstanding in 2003 |
50 | 50 | ||||||
| Additional paid-in capital |
19,987 | 19,803 | ||||||
| Retained earnings |
(1,066 | ) | (2,004 | ) | ||||
| Treasury stock, at cost, 48,822 shares in 2004 and 2003 |
(261 | ) | (261 | ) | ||||
| Accumulated other comprehensive income |
759 | 511 | ||||||
| Total stockholders equity |
19,469 | 18,099 | ||||||
| $ | 95,491 | $ | 95,711 | |||||
See notes to financial statements
OPINION RESEARCH CORPORATION AND SUBSIDIARIES
Consolidated Statements of Income
(in thousands, except share and per share amounts)
(Unaudited)
| Three Months Ended March 31, | ||||||
| 2004 |
2003 | |||||
| Revenues |
$ | 47,961 | $ | 43,164 | ||
| Cost of revenues (exclusive of depreciation) |
33,718 | 29,806 | ||||
| Gross profit |
14,243 | 13,358 | ||||
| Selling, general and administrative expenses |
9,898 | 9,974 | ||||
| Depreciation and amortization |
942 | 946 | ||||
| Operating income |
3,403 | 2,438 | ||||
| Interest and other non-operating expenses, net |
1,599 | 1,173 | ||||
| Income before provision for income taxes |
1,804 | 1,265 | ||||
| Provision for income taxes |
866 | 532 | ||||
| Net income |
$ | 938 | $ | 733 | ||
| Net Income per common share: |
||||||
| Basic |
$ | 0.15 | $ | 0.12 | ||
| Diluted |
$ | 0.15 | $ | 0.12 | ||
| Weighted average common shares outstanding: |
||||||
| Basic |
6,148,927 | 6,042,809 | ||||
| Diluted |
6,334,952 | 6,068,124 | ||||
See notes to financial statements
OPINION RESEARCH CORPORATION AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(in thousands)
(Unaudited)
| Three Months Ended March 31, |
||||||||
| 2004 |
2003 |
|||||||
| Cash flows from operating activities |
||||||||
| Net income |
$ | 938 | $ | 733 | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: |
||||||||
| Depreciation and amortization |
942 | 946 | ||||||
| Non-cash interest expense |
455 | 244 | ||||||
| Change in: |
||||||||
| Accounts receivable |
(1,289 | ) | 985 | |||||
| Other assets |
(687 | ) | (469 | ) | ||||
| Accounts payable and accrued expenses |
(756 | ) | (787 | ) | ||||
| Deferred revenues |
702 | (193 | ) | |||||
| Other liabilities |
(151 | ) | 680 | |||||
| Net cash provided by operating activities |
154 | 2,139 | ||||||
| Cash flows from investing activities: |
||||||||
| Capital expenditures |
(300 | ) | (643 | ) | ||||
| Net cash used in investing activities |
(300 | ) | (643 | ) | ||||
| Cash flows from financing activities: |
||||||||
| Borrowings under line-of-credit agreements |
6,158 | 10,710 | ||||||
| Repayments under line-of-credit agreements |
(7,117 | ) | (11,050 | ) | ||||
| Repayments of notes payable |
(750 | ) | (1,500 | ) | ||||
| Payments of loan amendment fees |
(75 | ) | (255 | ) | ||||
| Repayments under capital lease arrangements |
(24 | ) | (6 | ) | ||||
| Proceeds from the sale of common stock and options |
184 | 145 | ||||||
| Net cash used in financing activities |
(1,624 | ) | (1,956 | ) | ||||
| Effect of exchange rate changes on cash and cash equivalents |
66 | (45 | ) | |||||
| Decrease in cash and cash equivalents |
(1,704 | ) | (505 | ) | ||||
| Cash and cash equivalents at beginning of period |
2,766 | 2,549 | ||||||
| Cash and cash equivalents at end of period |
$ | 1,062 | $ | 2,044 | ||||
| Non-cash investing and financing activities: |
||||||||
| Acquisition of equipment under capital lease |
$ | 52 | $ | 244 | ||||
See notes to financial statements
OPINION RESEARCH CORPORATION AND SUBSIDIARIES
Notes to Consolidated Financial Statements
March 31, 2004
(Unaudited)
(in thousands, except shares and per share data)
NOTE A - BASIS OF PRESENTATION
The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three-month period ended March 31, 2004 are not necessarily indicative of the results that may be expected for the year ending December 31, 2004. For further information, refer to the consolidated financial statements and footnotes thereto included in the Registrant Company and Subsidiaries Annual Report on Form 10-K for the year ended December 31, 2003.
In the statement of cash flows for the period ended March 31, 2003, $250 in other assets has been reclassified to payments of loan amendment fees in the cash flows from financing activities to conform to the current period presentation.
NOTE B - CREDIT FACILITIES
The Company is required to maintain certain financial covenants under its credit facilities, such as minimum earnings, debt-to-earnings, interest coverage and other financial ratios. In March 2004, the Company amended a financial covenant under its then outstanding senior credit facility and subordinated debentures to be less restrictive. The Company incurred an amendment fee of $75. For the measuring period ended March 31, 2004, the Company was in compliance with all of the financial covenants.
In May 2004, the Company entered into a new secured revolving credit facility of $35,000 with two financial institutions (the Senior Revolving Facility). The Senior Revolving Facility is for a three-year term and is secured by substantially all of the assets of the Company. The Senior Revolving Facility carries an interest rate at the discretion of the Company of either the financial institutions designated base rate (4% at April 30, 2004) plus 100 basis points or LIBOR (3-month LIBOR was 1.18% at April 30, 2004) plus 300 basis points. Upon closing, the Company had approximately $5,161 of additional credit available under the Senior Revolving Facility.
In May 2004, the Company also issued $10,000 of secured subordinated notes (the Secured Subordinated Notes) and $12,000 of unsecured subordinated notes (the Unsecured Subordinated Notes) to a financial institution. The Secured Subordinated Notes carry an interest rate of 10% and will mature in November 2007. The Secured Subordinated Notes
require principal payments of $500 per quarter commencing July 1, 2004, with an unamortized balance of $3,000 due at the end of the term. The Unsecured Subordinated Notes expire in May 2009 and carry a fixed interest rate of 15.5%; 13% is payable quarterly in cash, and 2.5%, at the discretion of the Company, may be paid in cash or deferred and included in the outstanding principal balance until maturity. In exchange for consideration received in connection with this debt, the Company extended the life of existing warrants held by the financial institution from May 2007 to the later of May 2009 or the third anniversary of the repayment date. These warrants were issued in 1999 to the financial institution and are for the purchase of 437,029 shares of the Companys common stock at an exercise price of $5.422 per share. The extension of these warrants is valued at $616 and will be accreted through interest expense over the life of the Unsecured Subordinated Notes.
All debt outstanding as of May 4, 2004 was repaid with proceeds from the above borrowings. In conjunction with its new credit facilities, the Company incurred additional costs of approximately $1,430 which will be recorded in other long term assets in the Companys consolidated financial statements and amortized over the remaining terms of the facilities, commencing in the second quarter of 2004. Due to the refinancing described herein, the Company will also write off the unamortized loan fees of approximately $2,640 related to the retired debt as interest expense in the second quarter of 2004.
NOTE C - EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted earnings per share:
| Three Months Ended March 31, | ||||||
| 2004 |
2003 | |||||
| Numerator: |
||||||
| Net income |
$ | 938 | $ | 733 | ||
| Numerator for basic and diluted earnings per share |
$ | 938 | $ | 733 | ||
| Denominator: |
||||||
| Denominator for basic earnings per share |
||||||
| Weighted-average shares |
6,149 | 6,043 | ||||
| Effect of dilutive stock options |
186 | 25 | ||||
| Denominator for diluted earnings per share |
||||||
| Adjusted weighted-average shares |
6,335 | 6,068 | ||||
| Net income per common share: |
||||||
| Basic |
$ | 0.15 | $ | 0.12 | ||
| Diluted |
$ | 0.15 | $ | 0.12 | ||
NOTE D - STOCK-BASED COMPENSATION
The Company accounts for its employee stock option plans under Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees (APB 25) and related interpretations. The Company has adopted the disclosure-only provisions of Statement 123, Stock-Based Compensation and Statement 148, Accounting for Stock-Based Compensation Transition and Disclosure, which was released in December 2002 as an amendment of Statement 123. The following table illustrates the effect on net income and earnings per share if the fair value based method had been applied to all stock option awards:
| Three Months Ended March 31, |
||||||||
| 2004 |
2003 |
|||||||
| Net income as reported |
$ | 938 | $ | 733 | ||||
| Add: stock-based employee compensation expense included in reported net income, net of related tax effects |
| | ||||||
| Deduct: total stock-based employee compensation expense determined under fair value method for all awards, net of related tax effects |
(64 | ) | (101 | ) | ||||
| Net income pro forma |
$ | 874 | $ | 632 | ||||
| Basic earnings per share as reported |
$ | .15 | $ | .12 | ||||
| Basic earnings per share pro forma |
$ | .14 | $ | .10 | ||||
| Diluted earnings per share - as reported |
$ | .15 | $ | .12 | ||||
| Diluted earnings per share - pro forma |
$ | .14 | $ | .10 | ||||
The fair value of each option grant is estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions:
| 2004 |
2003 | |||
| Expected dividend yield |